Meloxidyl

RSS

meloxicam

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR). Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 12/03/2018

Authorisation details

Product details
Name
Meloxidyl
Agency product number
EMEA/V/C/000115
Active substance
meloxicam
International non-proprietary name (INN) or common name
meloxicam
Species
  • Dogs
  • Cats
  • Cattle
  • Pigs
  • Horses
Anatomical therapeutic chemical veterinary (ATCvet) codes
QM01AC06
Generic

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic medicines.

Publication details
Marketing-authorisation holder
Ceva Santé Animale
Revision
13
Date of issue of marketing authorisation valid throughout the European Union
15/01/2007
Contact address
10 avenue de la Ballastière
33500 Libourne
France

Product information

18/01/2018 Meloxidyl - EMEA/V/C/000115 - II/0023/G

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Anti inflammatory and antirheumatic products
  • non steroids (oxicams)

Therapeutic indication

Dogs

Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders.

Reduction of post-operative pain and inflammation following orthopaedic and soft-tissue surgery.

Cats

Reduction of post-operative pain after ovariohysterectomy and minor soft-tissue surgery.

Cattle

For use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle.

For use in diarrhoea in combination with oral rehydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.

For adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.

Pigs

For use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation.

For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.

Horses

For use in the alleviation of inflammation and relief of pain in both acute and chronic musculoskeletal disorders.

For the relief of pain associated with equine colic.

Assessment history

How useful was this page?

Add your rating